22.626 articles found

From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease.

Millan MJ.

Pharmacol Ther · 2010-06-26

DOI: 10.1016/j.pharmthera.2010.06.002PMID: 20600305

Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.

Qian L, Flood PM, Hong JS.

J Neural Transm (Vienna) · 2010-06-23

DOI: 10.1007/s00702-010-0428-1PMID: 20571837

DNA damage in brain cells and behavioral deficits in mice after treatment with high doses of amantadine.

Kaefer V, Semedo JG, Silva Kahl VF, Von Borowsky RG, Gianesini J, Ledur Kist TB, Pereira P, Picada JN.

J Appl Toxicol · 2010-06-23

DOI: 10.1002/jat.1550PMID: 20575081

Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

Skapinakis P, Bakola E, Salanti G, Lewis G, Kyritsis AP, Mavreas V.

BMC Neurol · 2010-06-21

DOI: 10.1186/1471-2377-10-49PMID: 20565960

Transcranial direct current stimulation as a treatment for Parkinson's disease--interesting, but not ready for prime time.

Chen R.

J Neurol Neurosurg Psychiatry · 2010-06-19

DOI: 10.1136/jnnp.2010.205112PMID: 20562431

Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible.

Keshtgar MR, Vaidya JS, Tobias JS, Wenz F, Joseph D, Stacey C, Metaxas MG, Keller A, Corica T, Williams NR, Baum M.

Int J Radiat Oncol Biol Phys · 2010-06-18

DOI: 10.1016/j.ijrobp.2010.01.045PMID: 20646864

Therapeutic Agents Useful for Treating Pain

SUN QUN, WEN XIN.

· 2010-06-17

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF BRAIN DISEASES AND CONDITIONS

LI MING, ZHOU ZHEN.

· 2010-06-11

Compositions and methods for prevention and treatment of brain diseases and conditions

LI MING, ZHOU ZHEN.

· 2010-06-11

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF BRAIN DISEASES AND CONDITIONS

LI MING, ZHOU ZHEN.

· 2010-06-11

Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia.

Tan T, Cabrita IZ, Hensman D, Grogono J, Dhillo WS, Baynes KC, Eliahoo J, Meeran K, Robinson S, Nihoyannopoulos P, Martin NM.

Clin Endocrinol (Oxf) · 2010-06-09

DOI: 10.1111/j.1365-2265.2010.03827.xPMID: 20550538

Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease.

Biju K, Zhou Q, Li G, Imam SZ, Roberts JL, Morgan WW, Clark RA, Li S.

Mol Ther · 2010-06-08

DOI: 10.1038/mt.2010.107PMID: 20531393